Who owns the IP
The organizations most actively patenting around this compound, ranked by referenced patent volume.
| # | Assignee | Patents |
|---|---|---|
| 1 | Pfizer Inc | 28 |
| 2 | Viatris Inc | 28 |
| 3 | Kala Bio Inc | 23 |
| 4 | Nippon Soda Co Ltd | 23 |
| 5 | Resonac Holdings Corp | 22 |
| 6 | Massachusetts Institute of Technology | 21 |
| 7 | Denka Co Ltd | 16 |
| 8 | GSK PLC | 16 |
| 9 | Ligand Pharmaceuticals Inc | 16 |
| 10 | Ezaki Glico Co Ltd | 12 |
Explore the full landscape
This preview shows the leading assignees. Cypris reveals the full ownership landscape - every filing entity, filing trends, and portfolio momentum.
Visit CyprisWhere innovation is concentrated
Patent classifications ranked by volume reveal the technical domains with the most active filing.
| # | Code | Area | Patents |
|---|---|---|---|
| 1 | A61K | Medicinal preparations | 620 |
| 2 | A61P | Therapeutic activity (drug indications) | 555 |
| 3 | C07D | Heterocyclic compounds | 180 |
| 4 | C07C | Acyclic and carbocyclic compounds | 71 |
| 5 | C12N | Microorganisms, enzymes | 66 |
| 6 | C05G | 61 | |
| 7 | C07K | Peptides | 60 |
| 8 | Y02A | Climate change adaptation | 60 |
| 9 | C05D | 58 | |
| 10 | C05F | 58 |
AI mapped opportunity space
This preview shows where patent activity concentrates. Cypris maps the full classification landscape to surface technical whitespace and IP headroom.
See Cypris in actionRepresentative patents
The filings that best characterise the patent activity around this compound, most-referenced first.
| Title | Year | Assignee | Cited by |
|---|---|---|---|
| COMBINATORIAL ANALYSIS AND REPAIR | 2010 | Agilent Technologies Inc | 143 |
| TREATMENT SYSTEMS FOR DELIVERY OF SENSITIZER SOLUTIONS | 2007 | 119 | |
| COMPOSITION AND METHOD FOR IMPROVING STABILITY AND EXTENDING SHELF LIFE OF PROBIOTIC BACTERIA AND FOOD PRODUCTS THEREOF | 2012 | 61 | |
| Myc modulators and uses thereof | 2018 | Massachusetts Institute of Technology | 33 |
| NASAL AND OPHTHALMIC DELIVERY OF AQUEOUS CORTICOSTEROID SOLUTIONS | 2008 | Ligand Pharmaceuticals Inc | 68 |
How research activity has moved
Papers published per year for this compound, over the last decade of indexed records.
| Year | Papers |
|---|---|
| 2016 | 373 |
| 2017 | 374 |
| 2018 | 339 |
| 2019 | 378 |
| 2020 | 348 |
| 2021 | 272 |
| 2022 | 409 |
| 2023 | 311 |
| 2024 | 300 |
| 2025 | 108 |
| 2026 | 1 |
Who's driving the science
The most-published authors working with this compound, alongside their primary affiliations.
| # | Author | Affiliation | Papers |
|---|---|---|---|
| 1 | Domen Leštan | University of Ljubljana | 36 |
| 2 | Claude F. Meares | University of California, Davis | 26 |
| 3 | Uwe Haberkorn | Heidelberg University | 23 |
| 4 | Franklin R. Tay | Augusta University | 22 |
| 5 | Ali Afshar‐Oromieh | Heidelberg University | 20 |
| 6 | Nidambur Vasudev Ballal | Manipal Academy of Higher Education | 16 |
| 7 | Wolfgang P. Fendler | Essen University Hospital | 16 |
| 8 | Tobias Maurer | Technical University of Munich | 14 |
| 9 | Richard F. Hurrell | ETH Zurich | 13 |
| 10 | Jérémie Calais | University of California, Los Angeles | 13 |
Research leaders
This preview lists the top authors. Cypris surfaces the full researcher landscape, their affiliations, and how scientific influence is shifting.
See Cypris in actionFrequently asked questions
Common questions about this compound's patent and research landscape, answered from the underlying data.
What is the molecular formula and weight of Edetate calcium disodium?
Which organizations hold the most patents for Edetate calcium disodium?
How much research activity has there been around Edetate calcium disodium in recent years?
What are the primary technical classifications for patents involving Edetate calcium disodium?
Who are the most prolific researchers publishing on Edetate calcium disodium?